Navigation Links
BioVex Announces Publication of Phase 2 Melanoma Results With OncoVEX (GM-CSF) in the Journal of Clinical Oncology
Date:11/2/2009

aneously administered GM-CSF in patients with unresectable Stage III (b-c) and Stage IV (M1a-c) melanoma. The primary endpoint is the rate of durable (maintained for six months) objective response. A total of 360 patients will be enrolled (240 to the OncoVEX arm and 120 to the control arm). The study design was agreed with the Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process, which provides agreement with the FDA that the trial's design, clinical endpoints and statistical analysis, if the study is successful, are appropriate to be used as the basis for regulatory approval.

About Metastatic Melanoma

According to the American Cancer Society, more than 8,000 people died in the U.S. of melanoma in 2008. Prevalence of Stage III and Stage IV disease is 120,000 and median survival for Stage IV disease is six months.

Treatment of melanoma depends on the stage of the disease with surgical resection being effective in the early stages of the disease. However, survival rates for the later Stage III and Stage IV patients are poor, reflecting the lack of effective drugs for recurrent or metastatic disease. Current systemic therapies are not generally effective in terms of generating durable responses or in impacting survival. As a result, many patients presenting with metastatic disease are directly enrolled into a clinical trial. The vast majority of experimental therapies to date have failed to show more than a single digit durable response rate.

About OncoVEX

The Company's lead cancer treatment, OncoVEX (GM-CSF) is a first-in-class oncolytic, or cancer destroying virus, that works by replicating and spreading within solid tumors (leaving healthy cells unaffected), thereby causing cancer cell death and stimulating the immune system to destroy un-injected metastatic deposits. Both modes of action have been clearly validated in the clinic, where multiple patients with metas
'/>"/>

SOURCE BioVex Inc
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
2. BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes
3. BioVex Reports Positive Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
4. BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting
5. BioVex Agrees SPA With the FDA for a Pivotal Study With OncoVEX(GM-CSF) in Metastatic Melanoma and Announces Presentation of Phase II Results at ASCO
6. PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
7. Arcadia Resources Announces Webcast of Its Fiscal 2010 Second Quarter Conference Call
8. ATS Medical Announces First in World Human Robotic Endoscopic Aortic Valve Replacement
9. Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.
10. Stryker Announces Change in Chairman of the Board of Directors
11. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... West Pharmaceutical Services, Inc. (NYSE: WST ) ... payment of the first-quarter 2010 cash dividend of $0.16 ... 3, 2010 to shareholders of record on January 20, ... is a global manufacturer of components and systems for ... and closures and disposable components used in syringe, IV ...
(Date:12/15/2009)... -- SRI International, an independent nonprofit research and ... patent 7,592,021 for a new bioadhesive drug delivery ... the human body,s mucous membranes. This needle-free option ... a much longer release time compared to alternatives ... is an effective means to introduce drugs across ...
(Date:12/15/2009)... Flextronics (Nasdaq: FLEX ) ... previously announced acquisition of SloMedical S.R.O., a ... ranging from tubing sets to complex devices ... Flextronics provides a broad set of capabilities ... customers. Terms of the deal were not ...
Breaking Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Flextronics Completes SloMedical Acquisition 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 1NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 2NOVAVAX Completes First Stage of Enrollment in Pivotal H1N1 Influenza Vaccine Study in the Country of Mexico 14845 3Triage Wireless Inc Becomes Sotera Wireless Inc 6282 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 1nContact Announces Initiation of Clinical Trials for the Treatment of Atrial Fibrillation in Open Chest Procedures 6278 2
... 27, 2007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX) ... pharmacokinetic study of,vaginally-administered lidocaine, which the Company ... 42-subject study was designed to provide data ... vaginal lidocaine,formulation at three dose strengths over ...
... of ONCONASE for,Treatment of Neuroblastoma, BLOOMFIELD, N.J., ... announced that new data show ONCONASE,the company's ... and,chemoresistant neuroblastoma cells. , The pre-clinical in ... Cancer,Letters (2007; Vol. 250, Issue 1: 107-116) ...
Other Medicine Technology:Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 2Columbia Laboratories Reports Positive Results from Multi-dose,Pharmacokinetic Study of Vaginally-administered Lidocaine 3In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3
(Date:12/15/2009)... -- The new compact LifeSpan TR200 folding treadmill, made ... ), was highly praised by treadmill review groups in ... compact TR200 folding treadmill received awards for Best New ... ,, The compact LifeSpan TR200 treadmill is designed ... "This category buster is a very compact treadmill that ...
(Date:12/15/2009)... of 30 Individuals Charged in Miami, Detroit and ... Billing to Medicare ,, WASHINGTON, Dec. ... in three cities for their alleged roles in ... false Medicare claims as part of the continuing ... of Health and Human Services (HHS) Secretary Kathleen ...
(Date:12/15/2009)... chronic obstructive pulmonary disease, or COPD, with increased activity ... body,s immune system. , The University of Michigan ... the immune system,s role in COPD, a serious, progressive ... with wheezing, shortness of breath, chest tightening and other ... to find better ways to detect and treat the ...
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
(Date:12/15/2009)... changes increases risk in teens, study suggests , , TUESDAY, ... or obese increases the risk of obstructive sleep apnea, ... for younger children, Australian researchers have found. , In ... to 18, who were referred for evaluation of snoring ... among those aged 12 and older the risk of ...
Breaking Medicine News(10 mins):Health News:Treadmill Reviews Rate Compact LifeSpan Treadmill Best Treadmill 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 2Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 3Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 4Health News:Medicare Fraud Strike Force Expands Operations Into Brooklyn, N.Y.; Tampa, Fla.; and Baton Rouge, La. 5Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2
... Therapy Association (APTA) has said that "Blackberry Thumb" should ... is a repetitive-stress injury that// occurs due to the ... ,"The use of PDAs (personal digital assistants) is no ... workplace," said Margot Miller, president of the APTA's Occupational ...
... Lionel Richie was so fearful over his daughter Nicole's drastic weight ... and find out the problem.// ,According to contactmusic.com, Richie ... she had an eating disorder. ,He says: "Believe ... you know, I went to her, and I said, 'Okay, what ...
... Babies are exposed to certain harmful chemicals before they are ... the need for pregnant women to be careful about their ... at the University of Granada, Spain, tested blood samples taken ... 15 different types of pesticide, reported the online edition of ...
... of Kansas Hospital have a new tool in the ... that has been helping doctors// in other areas improve ... the past several months Dr. William Smith and Dr. ... imaging center, have been working with new software for ...
... say that there is nothing that matches gambling. Not even ... addict//. ,There has been an upsurge of gambling ... with gambling problems. According to some experts, this has led ... ,"It's related to other addictions, like alcoholism and tobacco addiction. ...
... doctors specializing in sports medicine today to meet the level ... hosted by UK. ,Presently physicians are calling on primary ... of treat sports injuries as well as to help tackle ... Royal College of Physicians specialists are the key to improving ...
Other Medicine News:Health News:Babies in Womb Exposed to Harmful Chemicals 2Health News:Compulsive Gambling – a psychiatric disorde 2Health News:Sports Doctors too few for 2012 Olympics 2
... SOF'WIRE Cable System provides immediate, stable, ... to conventional monofilament wire, SOF'WIRE is ... with ease and reproducibility. Stainless Steel ... optimal strength, durability and conformity. ...
... Minimally Invasive Hip Instruments are ... through a mini-incision using a ... of instruments helps reduce the ... THA by optimizing exposure and ...
The Endotrac™ System includes an Obturator, Slotted Cannula, Synovial Elevator, Ligament Probe, Ligament Rasp, Blade Handle, two Retractors and sterilizable tray. The Endotrac&trade....
Instrument set for carpal tunnel release....
Medicine Products: